Ashish Arora, CEO of Cricut, sells $397k in CRCT stock

Cricut CEO Ashish Arora sold 63,750 shares of CRCT stock for approximately $397,302 between September 9-11, 2025, under a pre-arranged Rule 10b5-1 trading plan. This insider transaction follows a period of strong performance for CRCT, with shares up over 35% in six months, and coincides with the company reporting robust Q2 2025 earnings that significantly surpassed analyst expectations, posting EPS of $0.11 against a $0.06 forecast and revenue of $172.1 million versus a $158.59 million projection. Arora retains a substantial direct ownership of 2,845,311 shares.

Analysis

Cricut, Inc. (CRCT) reported a significant operational outperformance in its second-quarter 2025 results, substantially exceeding analyst expectations. The company posted earnings per share of $0.11, an 83.33% surprise above the $0.06 forecast, while revenue reached $172.1 million, beating the consensus estimate of $158.59 million. This strong fundamental performance aligns with the stock's recent momentum, which has seen a gain of over 35% in the past six months, and an external 'GREAT' financial health score. Concurrently, CEO Ashish Arora sold 63,750 shares for approximately $397,302. However, the context of this transaction mitigates typical concerns associated with insider selling. The sales were conducted under a pre-established Rule 10b5-1 trading plan adopted in August 2024, indicating a planned divestiture rather than a reaction to immediate market conditions. Furthermore, the sold shares represent a minor fraction of the CEO's total holdings, as he retains a substantial stake of 2,845,311 shares, suggesting continued significant alignment with shareholder interests.

Key Decisions for Investors

• Investors should weigh the significant Q2 2025 earnings and revenue beat, which signals strong fundamental health, more heavily than the CEO's recent share sale given its pre-planned nature.
• Note that the CEO's stock sale was executed under a Rule 10b5-1 plan, which typically serves for personal financial planning and reduces concerns that the sale is based on adverse non-public information.
• Given the stock's over 35% appreciation in the last six months, it is prudent to monitor whether future operational performance can continue to justify the elevated valuation and sustain the positive momentum.